European consensus statement on expert colposcopy
Language English Country Ireland Media print-electronic
Document type Review, Journal Article, Consensus Development Conference
PubMed
37716200
DOI
10.1016/j.ejogrb.2023.08.369
PII: S0301-2115(23)00676-0
Knihovny.cz E-resources
- Keywords
- Cancer, Cervix, Colposcopy, European guideline, Screening,
- MeSH
- Early Detection of Cancer MeSH
- Uterine Cervical Dysplasia * diagnosis MeSH
- Papillomavirus Infections * diagnosis MeSH
- Colposcopy MeSH
- Humans MeSH
- Uterine Cervical Neoplasms * MeSH
- Papillomaviridae MeSH
- Pregnancy MeSH
- Check Tag
- Humans MeSH
- Pregnancy MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Consensus Development Conference MeSH
- Review MeSH
BACKGROUND: Following the publication of the European consensus statement on standards for essential colposcopy in 2020, the need for standards relating to more complex and challenging colposcopy practice was recognised. These standards relate to colposcopy undertaken in patients identified through cervical screening and tertiary referrals from colposcopists who undertake standard colposcopy only. This set of recommendations provides a review of the current literature and agreement on care for recognised complex cases. With good uptake of human papillomavirus (HPV) immunisation, we anticipate a marked reduction in cervical disease over the next decade. Still, the expert colposcopist will continue to be vital in managing complex cases, including previous cervical intraepithelial neoplasia (CIN)/complex screening histories and multi-zonal disease. AIMS: To provide expert guidance on complex colposcopy cases through published evidence and expert consensus. MATERIAL & METHODS: Members of the EFC and ESGO formed a working group to identify topics considered to be the remit of the expert rather than the standard colposcopy service. These were presented at the EFC satellite meeting, Helsinki 2021, for broader discussion and finalisation of the topics. RESULTS & DISCUSSION: The agreed standards included colposcopy in pregnancy and post-menopause, investigation and management of glandular abnormalities, persistent high-risk HPV+ with normal/low-grade cytology, colposcopy management of type 3 transformation zones (TZ), high-grade cytology and normal colposcopy, colposcopy adjuncts, follow-up after treatment with CIN next to TZ margins and follow-up after treatment with CIN with persistent HPV+, and more. These standards are under review to create a final paper of consensus standards for dissemination to all EFC and ESGO members.
Aberdeen Centre for Women's Health Research University of Aberdeen UK
Department of Gynaecology Georgian National Screening Center Tbilisi Georgia
Department of Obstetrics and Gynaecology CUF Sintra Hospital Sintra Portugal
Department of Obstetrics and Gynecology University of Helsinki and Helsinki University Hospital
Department of Oncology and Radiology Danylo Halytsky Lviv national medical university Lviv Ukraine
Diakonessenhuis Bosboomstraat 1 3582 KE Utrecht the Netherlands
Frauenheilkunde and Geburtshilfe Zytologisches Labor Dysplasie Sprechstunde Düsseldorf Germany
Frauenklinik Baselland Switzerland
Gynaecology Centre North Estonia Medical Centre Estonia
IRDB MDR and Surgery and Cancer Faculty of Medicine Imperial College London UK
References provided by Crossref.org